Although the expression and function of CB1 and CB2 receptors, and of the eCB-metabolizing enzyme FAAH, has been widely studied in whole peripheral blood cells of several neurodegenerative diseases [5,6,20], as of yet no studies have addressed their expression within the different subsets of the immune system. Here, CNR1 is linked to neurodegenerative disease.